3/15/2013 Cryo-Cell International Affiliate Earns Patent For Processing Umbilical Cord Blood For Therapeutic Use in Treating Neurodegenerative Diseases and Spinal Cord and Brain Injuries
1/8/2013 Cryo-Cell International Chief Scientific Officer Optimistic That an Effective Treatment May be Found for Disability that Affects 10,000 Children Annually.
11/13/2012 Second Stem Cell Expert from Harvard’s Dana-Farber Cancer Institute Joins Cryo-Cell International
5/3/2012 Cryo-Cell International Taps Leader in Stem Cell Therapy to Serve as Chief Scientific Officer
3/5/2012 Cryo-Cell's Affiliate, Saneron CCEL Therapeutics, Releases Pre-Clinical Data Indicating That Cord Blood Stem Cells Slow Progression of ALS
2/6/2012 Cryo-Cell International, Inc. Announces Material Transfer Agreement with Stanford University
6/22/2011 Cryo-Cell Announces Global Expansion in Latin America
6/21/2011 Cryo-Cell International Shares Recognized in the Healthcare Services Industry for the Lowest Price to Earnings (P/E) Ratio
5/2/2011 Cryo-Cell Announces Advanced New Service and Exclusive Family Healthcare Protection Plan
3/15/2011 Cryo-Cell Featured in Article by CBS Phoenix, AZ Affiliate KPHO on Benefits of Menstrual Blood Banking
3/8/2011 Cryo-Cell Announces Publication of Collective Paper Outlining Potential Benefits of Transplanting Umbilical Cord and Menstrual Blood-Derived Stem Cells